Trial Profile
Bivalirudin Plus Prasugrel vs Abciximab Plus Clopidogrel. Optimizing Ischemic Protection and Bleeding Risk in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2024
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Prasugrel (Primary) ; Abciximab; Clopidogrel
- Indications Coronary thrombosis
- Focus Adverse reactions
- 29 Jul 2010 New trial record